Predictors of Natriuretic Peptide Non-Response in Patients Hospitalized With Acute Heart Failure

被引:13
作者
Ribeiro, Ana [1 ]
Lourenco, Patricia [1 ,2 ]
Silva, Sergio [1 ,3 ]
Cunha, Francisco [1 ]
Vilaca, Joao [1 ]
Gomes, Filipa [1 ]
Araujo, Jose Paulo [1 ,2 ]
Bettencourt, Paulo [1 ,2 ]
机构
[1] Ctr Hosp Sao Joao, Med Interna Serv, Oporto, Portugal
[2] Univ Porto, Fac Med, Unidade I&D Cardiovasc Porto, P-4100 Oporto, Portugal
[3] Univ Porto, Fac Med, Inst Anat, P-4100 Oporto, Portugal
关键词
SERUM TOTAL CHOLESTEROL; PROBNP-GUIDED MANAGEMENT; PROGNOSTIC-SIGNIFICANCE; RISK-FACTOR; THERAPY; TRIAL; MORTALITY; CARE; GUIDELINES;
D O I
10.1016/j.amjcard.2014.09.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increasing natriuretic peptide (NP) levels are associated with worse heart failure (HF) outcomes. Predictors of NP nonresponse have not been studied. The aim of this study was to identify predictors of nondecreasing NP levels during episodes of acute HF. A retrospective analysis was conducted in patients prospectively included in a registry of acute HF, with the primary diagnosis of acute HF. The objective under analysis was B-type NP (BNP) response, defined as a >30% decrease in BNP during hospitalization. Percentage of BNP variation was calculated as: % BNP variation = [(admission BNP - discharge BNP)/admission BNP] x 100. A logistic regression analysis was performed to study potential predictors of NP nonresponse. A multivariate model was built. A total of 496 patients were studied: 28.2% were considered nonresponders to the implemented HF treatment strategy. Identified predictors of nonresponse were older age, chronic HF, lower admission systolic blood pressure, anemia, renal dysfunction, and lower sodium on admission, as well as lower admission albumin and lower admission total cholesterol. Admission BNP was not a predictor of response. The only identified independent predictor of nonresponse was a low admission total cholesterol level (cutoff 125 mg/dl), with an odds ratio of 2.55 (95% confidence interval 1.59 to 4.11). This remained valid when the analysis was stratified according to admission BNP (cutoff 2,000 pg/ml) and according to statin use. In conclusion, a low admission total cholesterol level was a strong and independent predictor of BNP nonresponse in patients admitted with acute HF. The ability of cholesterol to predict BNP nonresponse was valid for patients with intrinsically low cholesterol and in those with statin-induced low cholesterol. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 30 条
  • [1] Wasting as independent risk factor for mortality in chronic heart failure
    Anker, SD
    Ponikowski, P
    Varney, S
    Chua, TP
    Clark, AL
    WebbPeploe, KM
    Harrington, D
    Kox, WJ
    PooleWilson, PA
    Coats, AJS
    [J]. LANCET, 1997, 349 (9058) : 1050 - 1053
  • [2] N-Terminal Pro-B-Type Natriuretic Peptide-Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure A 3-Arm, Prospective, Randomized Pilot Study
    Berger, Rudolf
    Moertl, Deddo
    Peter, Sieglinde
    Ahmadi, Roozbeh
    Huelsmann, Martin
    Yamuti, Susan
    Wagner, Brunhilde
    Pacher, Richard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (07) : 645 - 653
  • [3] Lipids and atherosclerosis
    Choy, PC
    Siow, YL
    Mymin, D
    O, K
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2004, 82 (01) : 212 - 224
  • [4] Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy
    Christ, M
    Klima, T
    Grimm, W
    Mueller, HH
    Maisch, B
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (06) : 691 - 699
  • [5] Assessing the benefits of natriuretic peptides-guided therapy in chronic heart failure
    Cocco, Giuseppe
    Jerie, Paul
    [J]. CARDIOLOGY JOURNAL, 2015, 22 (01) : 5 - 11
  • [6] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
  • [7] ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
    Dickstein, Kenneth
    Cohen-Solal, Alain
    Filippatos, Gerasimos
    McMurray, John J. V.
    Ponikowski, Piotr
    Poole-Wilson, Philip Alexander
    Stromberg, Anna
    van Veldhuisen, Dirk J.
    Atar, Dan
    Hoes, Amo W.
    Keren, Andre
    Mebazaa, Alexandre
    Nieminen, Markku
    Priori, Silvia Gluliana
    Swedberg, Karl
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (10) : 933 - 989
  • [8] Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study
    Eurlings, Luc W. M.
    van Pol, Petra E. J.
    Kok, Wouter E.
    van Wijk, Sandra
    Lodewijks-van der Bolt, Cara
    Balk, Aggie H. M. M.
    Lok, Dirk J. A.
    Crijns, Harry J. G. M.
    van Kraaij, Dave J. W.
    de Jonge, Nicolaas
    Meeder, Joan G.
    Prins, Martin
    Pinto, Yigal M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (25) : 2090 - 2100
  • [9] Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
    Gaggin, Hanna K.
    Mohammed, Asim A.
    Bhardwaj, Anju
    Rehman, Shafiq U.
    Gregory, Shawn A.
    Weiner, Rory B.
    Baggish, Aaron L.
    Moore, Stephanie A.
    Semigran, Marc J.
    Januzzi, James L., Jr.
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : 626 - 634
  • [10] Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Lupi, Laura
    Ambrosy, Andrew P.
    Mentz, Robert J.
    Konstam, Marvin A.
    Nodari, Savina
    Subacius, Hans P.
    Fonarow, Gregg C.
    Bonow, Robert O.
    Gheorghiade, Mihai
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (04) : 574 - 581